HEALTHSTAT NEWS
STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
The California Supreme Court ruled in favor of Gilead Sciences in a case where patients alleged the company was negligent for delaying the development of a safer HIV drug. The court overturned a prior decision holding Gilead liable, alleviating concerns in the pharmaceutical industry about legal risks influencing drug development.
Mentioned
Related Signal
Adjacent reporting
- STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
- Opinion: Mifepristone court ruling makes drug development riskier for everyone
- STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
- STAT+: Supreme Court rejects challenge to Medicare drug price negotiation